Autolus Therapeutics plc submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for obecabtagene autoleucel (obe-cel).
AI Assistant
AUTOLUS THERAPEUTICS PLC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.